Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), and immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III.
Request for Sample Copy@ https://www.kdmarketresearch.com/sample/3411
The global blood plasma derivatives market was valued at $23,613 million in 2016, and is projected to reach $44,333 million at a CAGR of 9.3% from 2017 to 2023. The major factor that contributes towards the growth of the blood plasma derivatives market is increase in prevalence of life-threatening diseases such as immunodeficiency disorders and hemophilia. Moreover, other factors boosting the market growth include increase in awareness for blood & plasma donation, rise in geriatric population, and high adoption of blood plasma derivatives products. However, high cost of treatment and risks of side effects associated with the use of plasma derivatives hamper the market growth. Conversely, development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market.
The global blood plasma derivatives market is segmented on the basis of type, application, end user, and region. Based on type, the market is fragmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The applications covered in the study include hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand’s Disease (vWD), and other application. By end user, the market is classified into hospitals, clinics, and other end users. Region wise, it is analyzed for North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global blood plasma derivatives market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Key market segments
By Type
-Albumin
-Factor VIII
-Factor IX
-Immunoglobulin
-Hyperimmune Globulin
-Others
By Application
-Hemophilia
-Hypogammaglobulinemia
-Immunodeficiency Diseases
-von Willebrand’s disease (vWD)
-Other Application
By End User
-Hospitals
-Clinics
-Other End Users
By Region
-North America
-U.S.
-Canada
-Mexico
-Europe
-Germany
-France
-UK
-Italy
-Spain
-Rest of Europe
-Asia-Pacific
-China
-Japan
-India
-Australia
-South Korea
-Rest of Asia-Pacific
-LAMEA
-Brazil
-Saudi Arabia
-South Africa
-Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
-Grifols, S.A.
-SK Plasma Co., Ltd.
-Fusion Health Care Pvt. Ltd.
-Biotest AG
-Green Cross Corporation
-Baxter International Inc.
-LFB S.A.
-Octapharma AG
-CSL Limited
-Shire Plc.
Browse full Research Report with toc@ https://www.kdmarketresearch.com/report/3411/blood-plasma-derivatives-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. By Type
1.3.2. By Application
1.3.3. By End User
1.3.4. By Region
1.3.5. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. High prevalence of life threatening diseases
3.4.1.2. Growth in awareness about blood and plasma donation
3.4.1.3. Rise in geriatric population
3.4.1.4. High adoption of blood plasma derivatives
3.4.2. Restraints
3.4.2.1. High cost of blood plasma derivatives based therapy
3.4.2.2. Risks associated with plasma derivatives
3.4.3. Opportunities
3.4.3.1. Development of better methods for plasma derivatives manufacturing
3.4.3.2. Opportunities in emerging economies
3.4.4. Impact analyses
3.5. Government regulations
3.5.1. Plasma derivatives regulations in United States and Europe
CHAPTER 4: BLOOD PLASMA DERIVATIVES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Albumin
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Factor VIII
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Factor IX
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Immunoglobulin
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Hyperimmune globulin
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Others
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
CHAPTER 5: BLOOD PLASMA DERIVATIVES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast (value)
5.2. Hemophilia
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Hypogammaglobulinemia
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Immunodeficiency diseases
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. von Willebrand’s disease (vWD)
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Other application
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
CHAPTER 6: BLOOD PLASMA DERIVATIVES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Clinics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Other end users
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: BLOOD PLASMA DERIVATIVES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. North America blood plasma derivatives market, by country
7.2.2.1. U.S.
7.2.2.1.1. Market size and forecast, by type
7.2.2.1.2. Market size and forecast, by application
7.2.2.1.3. Market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Market size and forecast, by type
7.2.2.2.2. Market size and forecast, by application
7.2.2.2.3. Market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Market size and forecast, by type
7.2.2.3.2. Market size and forecast, by application
7.2.2.3.3. Market size and forecast, by end user
7.2.3. North America market size and forecast, by type
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Market size and forecast, by type
7.3.2.1.2. Market size and forecast, by application
7.3.2.1.3. Market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. Market size and forecast, by type
7.3.2.2.2. Market size and forecast, by application
7.3.2.2.3. Market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. Market size and forecast, by type
7.3.2.3.2. Market size and forecast, by application
7.3.2.3.3. Market size and forecast, by end user
7.3.2.4. Italy
7.3.2.4.1. Market size and forecast, by type
7.3.2.4.2. Market size and forecast, by application
7.3.2.4.3. Market size and forecast, by end user
7.3.2.5. Spain
7.3.2.5.1. Market size and forecast, by type
7.3.2.5.2. Market size and forecast, by application
7.3.2.5.3. Market size and forecast, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Market size and forecast, by type
7.3.2.6.2. Market size and forecast, by application
7.3.2.6.3. Market size and forecast, by end user
7.3.3. Europe market size and forecast, by type
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Market size and forecast, by type
7.4.2.1.2. Market size and forecast, by application
7.4.2.1.3. Market size and forecast, by end user
7.4.2.2. China
7.4.2.2.1. Market size and forecast, by type
7.4.2.2.2. Market size and forecast, by application
7.4.2.2.3. Market size and forecast, by end user
7.4.2.3. India
7.4.2.3.1. Market size and forecast, by type
7.4.2.3.2. Market size and forecast, by application
7.4.2.3.3. Market size and forecast, by end user
7.4.2.4. Australia
7.4.2.4.1. Market size and forecast, by type
7.4.2.4.2. Market size and forecast, by application
7.4.2.4.3. Market size and forecast, by end user
7.4.2.5. South Korea
7.4.2.5.1. Market size and forecast, by type
7.4.2.5.2. Market size and forecast, by application
7.4.2.5.3. Market size and forecast, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Market size and forecast, by type
7.4.2.6.2. Market size and forecast, by application
7.4.2.6.3. Market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by type
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Market size and forecast, by type
7.5.2.1.2. Market size and forecast, by application
7.5.2.1.3. Market size and forecast, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Market size and forecast, by type
7.5.2.2.2. Market size and forecast, by application
7.5.2.2.3. Market size and forecast, by end user
7.5.2.3. South Africa
7.5.2.3.1. Market size and forecast, by type
7.5.2.3.2. Market size and forecast, by application
7.5.2.3.3. Market size and forecast, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Market size and forecast, by type
7.5.2.4.2. Market size and forecast, by application
7.5.2.4.3. Market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by type
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
Check for Discount @ https://www.kdmarketresearch.com/discount/3411
About Us:
KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.
Contact us -
KD Market Research
150 State Street, Albany,
New York, USA 12207
Website: www.kdmarketresearch.com
Email id- sales@kdmarketresearch.com
More - https://kdmarketresearch.blogspot.com/
No comments:
Post a Comment